Lantern Pharma Launches ZetaOmics™ — an Autonomous, Intelligent "Computational Biologist" That Brings Expert-Grade Bioinformatics, Biostatistics & R…

Lantern Pharma Inc. (NASDAQ: LTRN), a clinical-stage, AI-driven precision oncology company, today announced the launch of ...
Le Lézard

Lantern Pharma Launches ZetaOmicstm ? an Autonomous, Intelligent "Computational Biologist" That Brings Expert-Grade Bioinformatics, Biostatistics & Reasoning to Every Cancer

Lantern Pharma Inc. , a clinical-stage, AI-driven precision oncology company, today announced the launch of ZetaOmics, the computational-biology module of its multi-agentic AI co-scientist platform, ...

The Genes That Could Cancel Out a Fatal Diagnosis

Abraham Lincoln, for one, may have had the syndrome—and are at very high risk of a kind of fatal rupture in the heart.
New Scientist on MSN

I have a 100 per cent chance of getting cancer due to a rare gene

A rare variant of a gene called TP53 means Tracy Hutchinson has an extreme risk of developing cancer anywhere in her body, ...
Harvard Medical School

New Tool Helps Uncover Rare Genetic Mutations in Common Diseases, Including Parkinson’s

A new statistical framework could speed up the search for rare mutations that cause common diseases, helping researchers zero ...
RMD Open

Rare variants in genes related to inborn errors of immunity in patients with rheumatoid arthritis and secondary immunodeficiency

Objectives Treatment of rheumatoid arthritis (RA) relies on immunomodulatory drugs that can compromise immunity, inducing secondary immunodeficiency (SID). However, features of SID, such as ...
NPR

Your DNA is changing all the time. Here’s why

We tend to think of the DNA strands that contain our genetic code as consistent, stable units. But in reality, the cells that make up our bodies are constantly replicating and changing. Even as you ...